Menu

Rajiv Gandhi Cancer Institute & Research Centre

New Delhi, Delhi India

Claim This Site

Are you the site administrator? Claim this site to update information.

57Total Trials
14Recruiting Trials
30Active Trials
26Completed Trials
62Unique Conditions
24Unique Sponsors

Conditions

Breast Cancer (5)Carcinoma, Non-Small-Cell Lung (4)Breast Neoplasms (2)Colorectal Neoplasms (2)Paroxysmal Nocturnal Hemoglobinuria (2)Prostate Cancer (2)Acute Myeloid Leukemia (1)Adult Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia (1)

Sponsors

Pfizer (15)Rajiv Gandhi Cancer Institute & Research Center, India (11)Hoffmann-La Roche (8)Janssen Research & Development, LLC (4)Merck Sharp & Dohme LLC (4)Eli Lilly and Company (3)Regeneron Pharmaceuticals (2)Takeda (2)

Basic Information

Site Overview

Rajiv Gandhi Cancer Institute & Research Centre (RGCIRC) is one of Asia’s foremost dedicated cancer treatment and research centres, established in 1996 as a project of the Indraprastha Cancer Society & Research Centre. It operates major campuses in Rohini (North Delhi) and Niti Bagh (South Delhi), offering comprehensive oncology care backed by advanced technology and multidisciplinary expertise. RGCIRC provides a full spectrum of cancer services including medical oncology, surgical oncology, radiation oncology, paediatric oncology, bone marrow transplant, nuclear medicine, pathology, and supportive/palliative care. The institute combines evidence-based clinical practice with cutting-edge treatments and robust diagnostic facilities such as PET-CT and modern laboratories, serving patients from across India and neighbouring countries. With round-the-clock emergency services, specialised tumour boards, telemedicine and a focus on research and education, RGCIRC is recognised for quality…

Accessibility & Parking

Accessibility Features

Wheelchair accessible entrance
Wheelchair accessible parking lot
Wheelchair accessible restroom
Wheelchair accessible seating

Amenities

Amenities Available

Restroom
Gender-neutral restroom